Skip to main content
. Author manuscript; available in PMC: 2012 Apr 5.
Published in final edited form as: Breast Cancer Res Treat. 2007 Oct 27;111(3):419–427. doi: 10.1007/s10549-007-9798-y

Fig. 3.

Fig. 3

Inhibition of NF-κB activity of MCF7 cells and MCF7 sphere cells after treatment with PTL, PDTC and DETC. Cells were treated with PTL, PDTC and DETC at 5 µM for 24 h. Nuclear extract was prepared from control and treated cells. The quantification of NF-κB activation was performed using Trans-AM NF-κB kit from ActiveMotif